Introduction
============

Telocytes (TCs) were identified as a new cell type of the stromal space \[[@b1]\] (details at [www.telocytes.com](http://www.telocytes.com)). TCs were described in the trachea and lungs \[[@b2]--[@b5]\], besides other important locations: heart \[[@b6]--[@b9]\], female reproductive system \[[@b10]--[@b13]\], skin \[[@b14],[@b15]\], digestive system \[[@b16]--[@b19]\], liver \[[@b20]\], urinary tract \[[@b21],[@b22]\], prostate \[[@b23],[@b24]\], skeletal muscle and neuromuscular spindles \[[@b25],[@b26]\], eye \[[@b27]\], *etc*. Ultrastructurally, TCs are defined and easily to distinguish by their extremely long telopodes (tens up to hundreds of micrometres), an alternation of podoms and podomeres.

Recently, electrophysiological properties were described for TCs \[[@b28]--[@b30]\], their microarray-based gene expression analysis and microRNA signature were established \[[@b31],[@b32]\] and some of their genomic features were revealed \[[@b33]\]. In a previous study, we reported the proteomic profile differences between TCs and fibroblasts \[[@b34]\].

Since their description, it became clear that TCs develop a 3D network through the organ interstitial space and are frequently detected in close relationships with organ-specific structures, blood capillaries, nerve endings and even with stem cells niches and immune cells \[[@b11],[@b16],[@b29]\]. Numerous studies have described the unusual immunophenotype of the TCs providing a list of molecular markers such as CD34, PDGFR α and β, CD117 \[[@b20],[@b25],[@b35]--[@b37]\]. Some of these markers are also expressed on endothelial cells (low level of CD34) and on pericytes (PDGFR α and β). However ECs co-express CD31 and pericytes co-express α-SMA, while TCs do not \[[@b25]\]. These similarities might be suggestive for a common mesodermal pre-cursor for TCs, ECs and for a perivascular origin of mesenchymal stem cells (for reviews see [@b38]--[@b42]).

It is largely accepted that ECs in culture are subjected to phenotypic drift because of the lack of *in vivo* typical conditions \[[@b43]\], mainly oxygen exposure which is higher *in vitro*. These aspects together with the fact that proteomic studies also point out the differences between venous and arterial ECs \[[@b44]\] should lead us to the idea that *in vitro* culture studies should be viewed with circumspection without out-looking *in vivo* physiological influences. A study by Nguyen *et al*., regarding differential proteomic analysis of lymphatic, venous and arterial endothelial cells extracted from bovine mesenteric vessels underline the lack of substantial overlap between results from different research groups \[[@b45]\].

The present study shows the proteomic analysis of the TCs, by comparing them with ECs using iTRAQ labelling to identify the differentially expressed proteins. We think that the identification of a panel of 98 proteins at 5th day, and 82 proteins at 10th day in cell cultures, may represent the most differentially expressed proteins between TCs and ECs. We found that 38 proteins were overexpressed in TCs compared to ECs (at 5th day) and that 26 proteins were overexpressed in TCs compared to ECs (at 10th day). Bioinformatics analysis of the up-regulated proteins came again to confirm the involvement of TCs in intercellular communication, oxidative stress and cellular ageing. Also, TCs may have pro-proliferative effects through the inhibition of apoptosis.

Material and methods
====================

Cell lines and tissue sampling
------------------------------

Human lung samples were obtained from the patients undergoing surgery for lung cancer. Lung fragments were removed from normal tissue area located at least at 15 cm from the tumour tissue. All tissue samples were obtained in accordance with a protocol approved by the Ethical Evaluation Committee of Zhongshan Hospital, Fudan University, Shanghai, China. Samples were processed within 30 min. from surgery. Cells were cultured using the protocol previously described \[[@b34]\]. Human pulmonary microvascular endothelial cell line was obtained from ScienCell Research Laboratories (Cat. no. 3000; Carlsbad, CA, USA).

Cell culture and lysis
----------------------

Cells from primary culture were used for the experiments. Cells (1 × 10^5^) were placed in 10-cm dishes with 10 ml high glucose DMEM (Gibco, Grand Island, NY, USA) complete medium, including 10% foetal calf serum (Gibco, Grand Island, NY, USA), 100 UI/ml penicillin and 0.1 mg/ml streptomycin (Sigma Chemical, St. Louis, MO, USA) in a humidified atmosphere of 5% CO~2~ at 370°C. Confluent cells were trypsinized at day 5 and day 10 respectively. Approximately 10^6^ cells from day 5 or day 10 were re-suspended in a solution of 9.5 moles/l urea, 1% dithiothreitol, 40 mg/ml protease inhibitor cocktail, 0.2 mmoles/l Na~2~VO~3~ and 1 mmole/l NaF. The mixture was incubated and stirred by end-over-end rotation at 4°C for 60 min. The resultant suspension was centrifuged at 40,000 × g for 1 hr at 15°C. The supernatant was stored in small aliquots at −80°C, and the protein concentration was determined using a modified Bradford method.

Automated 2-D nano-ESI LC-MS/MS analysis of peptides
----------------------------------------------------

Proteins extracted from primary cultures of TCs and EC were analysed by automated 2-dimensional nano-electrospray ionization liquid chromatography tandem mass spectrometry as was previously described \[[@b46],[@b47]\].

Sample preparation
------------------

The samples were ground in liquid nitrogen. One millilitre of lysis buffer (8 M urea, 1× Protease Inhibitor Cocktail (Roche Ltd. Basel, Switzerland)) was added to sample, followed by sonication on ice and centrifugation at 29,000 × g for 10 min. at 4°C. The supernatant was transferred to a fresh tube, and stored at −80°C until needed.

iTRAQ labelling and protein digestion
-------------------------------------

For each sample, proteins were precipitated with ice-cold acetone, and then were redissolved in the dissolution buffer (0.5 M triethylammonium bicarbonate, 0.1% SDS). Then proteins were quantified by BCA protein assay, and 100 μg of protein was tryptically digested and the resultant peptide mixture was labelled using chemicals from the iTRAQ reagent kit (Applied Biosystems, Foster City, CA, USA). Disulphide bonds were reduced in 5 mM Tris-(2-carboxyethy) phosphine for 1 hr at 60°C, followed by blocking cysteine residues in 10 mM methyl methanethiosulfonate for 30 min. at room temperature, before digestion with sequence-grade modified trypsin (Promega, Madison, WI, USA). For labelling, each iTRAQ reagent was dissolved in 50 μl of isopropanol and added to the respective peptide mixture.

Proteins were labelled with the iTRAQ tags as follows: Pulmonary microvascular endothelial cells (5 days) - 113 isobaric tag, TCs (5 days) - 116 isobaric tag, Pulmonary microvascular endothelial cells (10 days) - 117 isobaric tag, TCs (10 days) - 121 isobaric tag. The labelled samples were combined and dried in vacuo. A SepPac™ C18 cartridge (1 cm^3^/50 mg; Waters Corporation, Milford, MA, USA) was used to remove the salt buffer and then was dried in a vacuum concentrator for the next step.

High pH reverse phase separation
--------------------------------

Using a described protocol \[[@b48]\], the peptide mixture was redissolved in the buffer A (buffer A: 20 mM ammonium formate in water, pH 10.0, adjusted with ammonium hydroxide), and then fractionated by high pH separation using a Aquity UPLC system (Waters Corporation) connected to a reverse phase column (XBridge C18 column, 2.1 mm × 150 mm, 3.5 μm, 300 Å; Waters Corporation). High pH separation was performed with a linear gradient. Starting from 2% B to 40% B in 45 min. (B: 20 mM ammonium formate in 90% ACN, pH 10.0, adjusted with ammonium hydroxide). The column was re-equilibrated at initial conditions for 15 min. The column flow rate was maintained at 200 μl/min. and column temperature was maintained at room temperature. Fourteen fractions were collected, and each fraction was dried in a vacuum concentrator for the next step.

Low pH nano-HPLC-MS/MS analysis
-------------------------------

The peptides were re-suspended with 80 μl solvent C (C: water with 0.1% formic acid; D: ACN with 0.1% formic acid), separated by nanoLC and analysed by on-line electrospray tandem mass spectrometry. The experiments were performed on a Nano Aquity UPLC system (Waters Corporation) connected to an LTQ Orbitrap XL mass spectrometer (Thermo Electron Corp., Bremen, Germany) equipped with an online nanoelectrospray ion source (Michrom Bioresources, Auburn, CA, USA). 20 μl peptide sample was loaded onto the Thermo Scientific Acclaim PepMap C18 column (100 μm × 2 cm, 3 μm particle size), with a flow of 10 μl/min. for 5 min. and subsequently separated on the analytical column (Acclaim PepMap C18, 75 μm × 15 cm) with a linear gradient, from 5% D to 45% D in 165 min. The column was re-equilibrated at initial conditions for 15 min. The column flow rate was maintained at 300 nl/min. and column temperature was maintained at 35°C. The electrospray voltage of 1.9 kV *versus* the inlet of the mass spectrometer was used.

LTQ Orbitrap XL mass spectrometer was operated after a protocol previously described \[[@b34]\].

Database searching and criteria
-------------------------------

Protein identification and quantification for the iTRAQ experiment was performed with the ProteinPilot software version 4.0 (Applied Biosystems). The database was the Human UniProtKB/Swiss-Prot database (Release 2011_10_15, with 20248 sequences). The Paragon Algorithm in ProteinPilot software was used for peptide identification and isoform specific quantification. The detailed method of ProteinPilot analysis was described previously \[[@b34]\]. For iTRAQ quantification, the peptide for quantification was automatically selected by Pro Group algorithm (at least two peptides with 99% confidence) to calculate the reporter peak area, error factor and *P*-value. For the selection of differentially expressed proteins, we considered the following situation: (1) the proteins must contain at least two unique high-scoring peptides; (2) the proteins must have a *P* \< 0.05, and the proteins identified with mass tag changes ratio must be ≥1.3 or ≤0.75. Differentially expressed proteins were screened by two-sample t-test (*P* \< 0.05) and fold change (\>2), based on the bioinformatics analysis.

The biological interpretation of the results was aided by PANTHER (Protein ANalysis THrough Evolutionary Relationships) Classification System annotations (<http://www.pantherdb.org/>).

Heat maps were created after MS/MS fragmentation spectra were analysed using PEAKS search engine tool (PEAKS Studio 7; Bioinformatics Solutions Inc., Waterloo, ON, Canada).

We also used the Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) (<http://www.string-db.org/>) database of physical and functional interactions to evaluate the interactions among the up-regulated proteins of the TCs and ECs. Bonferroni correction was used as a conservative method to control the family wise error rate when highlighting proteins involved in different biological processes.

Results
=======

Quantitative proteomics has been used to evaluate the differentially expressed proteins in TCs and ECs. We compared the protein expression profiles between those two cell types, at different moments in time (5th day and 10th day in cell culture). In particular, we identified a total of 1609 proteins of which 98 satisfied our filtering criteria of proteins that exhibited fold changes ≥2 in TCs *versus* ECs at day 5 (Table[1](#tbl1){ref-type="table"}), and 82 proteins in TCs *versus* ECs at day 10 (Table[2](#tbl2){ref-type="table"}), respectively.

###### 

Selected list of top 98 proteins identified with more than twofold change in TCs *versus* ECs at 5th day sorted by iTRAQ ratio and presenting the number of peptides hits

  Accession     Protein name                                                       Peptides (95%)   %Cov (95)   iTRAQ ratio ECs:TCs   Fold enrichment in TCs   *P*
  ------------- ------------------------------------------------------------------ ---------------- ----------- --------------------- ------------------------ --------
  MYH14_HUMAN   Myosin-14                                                          18               7.67        0.053                 18.84                    0.0002
  SODM_HUMAN    Superoxide dismutase \[Mn\], mitochondrial                         10               35.14       0.069                 14.59                    0.0002
  ASAH1_HUMAN   Acid ceramidase                                                    2                5.82        0.131                 7.63                     0.0315
  EVPL_HUMAN    Envoplakin                                                         1                0.79        0.161                 6.22                     0.0346
  EPIPL_HUMAN   Epiplakin                                                          17               16.07       0.167                 5.99                     0.0250
  HBB_HUMAN     Haemoglobin subunit beta                                           2                15.65       0.219                 4.56                     0.0466
  HBA_HUMAN     Haemoglobin subunit alpha                                          2                16.90       0.244                 4.09                     0.0055
  THIM_HUMAN    3-ketoacyl-CoA thiolase, mitochondrial                             12               33.50       0.245                 4.08                     0.0186
  SQRD_HUMAN    Sulphide:quinone oxidoreductase, mitochondrial                     9                19.78       0.245                 4.08                     0.0015
  LMO7_HUMAN    LIM domain only protein 7                                          3                2.02        0.246                 4.06                     0.0246
  FRIL_HUMAN    Ferritin light chain                                               1                8.57        0.252                 3.97                     0.0178
  ALDH2_HUMAN   Aldehyde dehydrogenase, mitochondrial                              5                10.06       0.253                 3.96                     0.0152
  TAGL_HUMAN    Transgelin                                                         15               75.12       0.258                 3.88                     0.0058
  ACADV_HUMAN   Very long-chain specific acyl-CoA dehydrogenase, mitochondrial     6                9.62        0.301                 3.33                     0.0325
  TPSN_HUMAN    Tapasin                                                            3                5.13        0.318                 3.14                     0.0292
  PGRC1_HUMAN   Membrane-associated progesterone receptor component 1              4                18.97       0.328                 3.04                     0.0068
  SUCA_HUMAN    Succinyl-CoA ligase \[GDP-forming\] subunit alpha, mitochondrial   5                17.63       0.344                 2.90                     0.0018
  ICAM1_HUMAN   Intercellular adhesion molecule 1                                  6                14.66       0.374                 2.67                     0.0021
  TFR1_HUMAN    Transferrin receptor protein 1                                     5                5.79        0.378                 2.65                     0.0073
  NLTP_HUMAN    Non-specific lipid-transfer protein                                9                12.43       0.390                 2.57                     0.0013
  CO1A1_HUMAN   Collagen alpha-1(I) chain                                          4                3.01        0.407                 2.46                     0.0290
  AT1A1_HUMAN   Sodium/potassium-transporting ATPase subunit alpha-1               17               18.77       0.412                 2.43                     0.0000
  COX5B_HUMAN   Cytochrome c oxidase subunit 5B, mitochondrial                     4                34.11       0.438                 2.28                     0.0042
  DHB4_HUMAN    Peroxisomal multifunctional enzyme type 2                          11               25.00       0.442                 2.26                     0.0000
  MYH10_HUMAN   Myosin-10                                                          45               19.59       0.445                 2.25                     0.0240
  KAD3_HUMAN    GTP:AMP phosphotransferase, mitochondrial                          2                10.57       0.451                 2.22                     0.0107
  CO4A_HUMAN    Complement C4-A                                                    4                2.52        0.460                 2.17                     0.0215
  COX5A_HUMAN   Cytochrome c oxidase subunit 5A, mitochondrial                     6                58.67       0.470                 2.13                     0.0015
  DLDH_HUMAN    Dihydrolipoyl dehydrogenase, mitochondrial                         10               27.50       0.472                 2.12                     0.0047
  ALBU_HUMAN    Serum albumin                                                      11               14.45       0.473                 2.11                     0.0098
  A2MG_HUMAN    Alpha-2-macroglobulin                                              7                4.34        0.476                 2.10                     0.0268
  ETHE1_HUMAN   Protein ETHE1, mitochondrial                                       2                9.45        0.480                 2.08                     0.0370
  KAD2_HUMAN    Adenylate kinase 2, mitochondrial                                  8                41.42       0.487                 2.05                     0.0004
  ERGI1_HUMAN   Endoplasmic reticulum-Golgi intermediate compartment protein 1     4                18.97       0.488                 2.05                     0.0258
  ERP29_HUMAN   Endoplasmic reticulum resident protein 29                          7                28.74       0.490                 2.04                     0.0015
  GRP75_HUMAN   Stress-70 protein, mitochondrial                                   32               40.94       0.493                 2.03                     0.0114
  ETFA_HUMAN    Electron transfer flavoprotein subunit alpha, mitochondrial        10               38.44       0.494                 2.02                     0.0002
  CH60_HUMAN    60 kD heat shock protein, mitochondrial                            60               62.30       0.496                 2.02                     0.0011

  Accession           Protein name                                           Peptides (95%)   %Cov (95)   iTRAQ ratio ECs:TCs   Fold enrichment in ECs   *P*
  ------------------- ------------------------------------------------------ ---------------- ----------- --------------------- ------------------------ --------
  PUR6_HUMAN          Multifunctional protein ADE2                           4                6.59        2.007                 2.01                     0.0375
  G6PI_HUMAN          Glucose-6-phosphate isomerase                          4                7.35        2.019                 2.02                     0.0029
  RS13_HUMAN          40S ribosomal protein S13                              5                29.80       2.025                 2.02                     0.0035
  PROF1_HUMAN         Profilin-1                                             23               75.71       2.026                 2.03                     0.0004
  TXND5_HUMAN         Thioredoxin domain-containing protein 5                15               40.51       2.030                 2.03                     0.0011
  LEG1_HUMAN          Galectin-1                                             27               91.11       2.053                 2.05                     0.0001
  ARC1B_HUMAN         Actin-related protein 2/3 complex subunit 1B           2                5.11        2.056                 2.06                     0.0126
  AMPN_HUMAN          Aminopeptidase N                                       7                7.03        2.061                 2.06                     0.0162
  LDHB_HUMAN          L-lactate dehydrogenase B chain                        8                23.35       2.094                 2.09                     0.0021
  ACLY_HUMAN          ATP-citrate synthase                                   11               11.08       2.096                 2.10                     0.0004
  THIO_HUMAN          Thioredoxin                                            5                51.43       2.115                 2.11                     0.0022
  GDIB_HUMAN          Rab GDP-dissociation inhibitor beta                    5                14.83       2.118                 2.12                     0.0007
  EEA1_HUMAN          Early endosome antigen 1                               4                2.62        2.140                 2.14                     0.0111
  TGM2_HUMAN          Protein-glutamine gamma-glutamyltransferase 2          18               21.25       2.145                 2.15                     0.0351
  RL19_HUMAN          60S ribosomal protein L19                              3                14.80       2.207                 2.21                     0.0133
  COF1_HUMAN          Cofilin-1                                              21               71.69       2.210                 2.21                     0.0138
  FLNB_HUMAN          Filamin-B                                              96               41.78       2.210                 2.21                     0.0000
  H15_HUMAN           Histone H1.5                                           7                23.45       2.219                 2.22                     0.0186
  RAN_HUMAN           GTP-binding nuclear protein Ran                        7                32.87       2.245                 2.25                     0.0117
  NQO1_HUMAN NAD(P)   H dehydrogenase \[quinone\] 1                          2                7.66        2.246                 2.25                     0.0206
  HS90B_HUMAN         Heat shock protein HSP 90-beta                         37               35.77       2.275                 2.27                     0.0006
  RCN1_HUMAN          Reticulocalbin-1                                       8                22.66       2.283                 2.28                     0.0093
  CDC37_HUMAN         Hsp90 co-chaperone Cdc37                               10               27.25       2.306                 2.31                     0.0005
  G3P_HUMAN           Glyceraldehyde-3-phosphate dehydrogenase               42               64.48       2.338                 2.34                     0.0045
  SH3L3_HUMAN         SH3 domain-binding glutamic acid-rich-like protein 3   3                34.41       2.341                 2.34                     0.0160
  ITA5_HUMAN          Integrin alpha-5                                       7                8.20        2.366                 2.37                     0.0011
  EHD2_HUMAN          EH domain-containing protein 2                         8                17.13       2.374                 2.37                     0.0009
  PPIA_HUMAN          Peptidyl-prolyl cis-trans isomerase A                  17               75.76       2.383                 2.38                     0.0001
  MOES_HUMAN          Moesin                                                 26               44.71       2.394                 2.39                     0.0054
  PRDX1_HUMAN         Peroxiredoxin-1                                        14               46.73       2.419                 2.42                     0.0006
  UCHL1_HUMAN         Ubiquitin carboxyl-terminal hydrolase isozyme L1       7                37.22       2.486                 2.49                     0.0033
  TAGL2_HUMAN         Transgelin-2                                           19               74.87       2.533                 2.53                     0.0000
  HPRT_HUMAN          Hypoxanthine-guanine phosphoribosyltransferase         2                11.01       2.570                 2.57                     0.0220
  PLST_HUMAN          Plastin-3                                              11               19.37       2.570                 2.57                     0.0000
  WDR1_HUMAN          WD repeat-containing protein 1                         10               18.15       2.577                 2.58                     0.0000
  UB2L3_HUMAN         Ubiquitin-conjugating enzyme E2 L3                     1                4.54        2.601                 2.60                     0.0052
  HMGB1_HUMAN         High mobility group protein B1                         3                15.35       2.614                 2.61                     0.0014
  TRXR1_HUMAN         Thioredoxin reductase 1, cytoplasmic                   9                16.49       2.618                 2.62                     0.0001
  NSF1C_HUMAN         NSFL1 cofactor p47                                     4                19.19       2.696                 2.70                     0.0192
  APEX1_HUMAN         DNA-(apurinic or apyrimidinic site) lyase              2                6.60        2.718                 2.72                     0.0292
  K6PP_HUMAN          6-phosphofructokinase type C                           5                8.29        2.741                 2.74                     0.0004
  HINT1_HUMAN         Histidine triad nucleotide-binding protein 1           3                40.48       2.775                 2.77                     0.0244
  STIP1_HUMAN         Stress-induced-phosphoprotein 1                        11               19.34       2.777                 2.78                     0.0000
  RL15_HUMAN          60S ribosomal protein L15                              2                7.84        2.792                 2.79                     0.0232
  S10AD_HUMAN         Protein S100-A13                                       5                44.90       2.832                 2.83                     0.0016
  CSRP1_HUMAN         Cysteine and glycine-rich protein 1                    3                21.76       2.843                 2.84                     0.0280
  VAT1_HUMAN          Synaptic vesicle membrane protein VAT-1 homologue      12               31.81       2.911                 2.91                     0.0012
  6PGD_HUMAN          6-phosphogluconate dehydrogenase, decarboxylating      5                10.77       2.952                 2.95                     0.0346
  SDPR_HUMAN          Serum deprivation-response protein                     3                9.18        3.146                 3.15                     0.0278
  GDIR1_HUMAN         Rho GDP-dissociation inhibitor 1                       4                18.14       3.740                 3.74                     0.0010
  FSCN1_HUMAN         Fascin                                                 6                16.63       4.026                 4.03                     0.0012
  HMGA1_HUMAN         High mobility group protein HMG-I/HMG-Y                2                22.43       4.281                 4.28                     0.0031
  PECA1_HUMAN         Platelet endothelial cell adhesion molecule            9                11.52       4.492                 4.49                     0.0131
  SCRN1_HUMAN         Secernin-1                                             2                5.80        4.937                 4.94                     0.0203
  VWF_HUMAN           von Willebrand factor                                  19               7.93        5.740                 5.74                     0.0002
  NEST_HUMAN          Nestin                                                 22               16.84       5.924                 5.92                     0.0000
  FKB1A_HUMAN         Peptidyl-prolyl cis-trans isomerase FKBP1A             4                34.26       6.650                 6.65                     0.0168
  KCD12_HUMAN         BTB/POZ domain-containing protein KCTD12               3                9.85        7.264                 7.26                     0.0038
  RAIN_HUMAN          Ras-interacting protein 1                              1                1.14        13.416                13.42                    0.0393
  MUC18_HUMAN         Cell surface glycoprotein MUC18                        7                12.69       15.540                15.54                    0.0050

###### 

Selected list of top 82 proteins identified with more than twofold change in TCs *versus* ECs at 10th day sorted by iTRAQ ratio and presenting the number of peptides hits

  Accession     Protein name                                                     Peptides (95%)   %Cov (95)   iTRAQ ratio ECs:TCs   Fold enrichment in TCs   *P*
  ------------- ---------------------------------------------------------------- ---------------- ----------- --------------------- ------------------------ --------
  PTGIS_HUMAN   Prostacyclin synthase                                            7                15.80       0.112                 8.93                     0.0016
  MUC1_HUMAN    Mucin-1                                                          2                1.75        0.199                 5.02                     0.0390
  EPIPL_HUMAN   Epiplakin                                                        17               16.07       0.209                 4.78                     0.0083
  SODM_HUMAN    Superoxide dismutase \[Mn\], mitochondrial                       10               35.14       0.222                 4.50                     0.0155
  AL1B1_HUMAN   Aldehyde dehydrogenase X, mitochondrial                          5                13.93       0.246                 4.06                     0.0133
  SERA_HUMAN    D-3-phosphoglycerate dehydrogenase                               4                8.07        0.295                 3.39                     0.0019
  CYB5_HUMAN    Cytochrome b5                                                    4                32.09       0.306                 3.27                     0.0483
  SQRD_HUMAN    Sulphide:quinone oxidoreductase, mitochondrial                   9                19.78       0.328                 3.05                     0.0000
  THIM_HUMAN    3-ketoacyl-CoA thiolase, mitochondrial                           12               33.50       0.338                 2.95                     0.0000
  ERGI1_HUMAN   Endoplasmic reticulum-Golgi intermediate compartment protein 1   4                18.97       0.348                 2.88                     0.0088
  EZRI_HUMAN    Ezrin                                                            19               31.40       0.354                 2.83                     0.0162
  CP51A_HUMAN   Lanosterol 14-alpha demethylase                                  2                3.98        0.361                 2.77                     0.0156
  PLOD2_HUMAN   Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2                15               22.39       0.370                 2.70                     0.0061
  CO1A2_HUMAN   Collagen alpha-2(I) chain                                        9                7.91        0.382                 2.62                     0.0001
  ECH1_HUMAN    Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial       4                23.78       0.385                 2.60                     0.0099
  RRS1_HUMAN    Ribosome biogenesis regulatory protein homologue                 3                9.86        0.393                 2.54                     0.0059
  ACADV_HUMAN   Very long-chain specific acyl-CoA dehydrogenase, mitochondrial   6                9.62        0.414                 2.41                     0.0449
  NB5R1_HUMAN   NADH-cytochrome b5 reductase 1                                   1                2.95        0.414                 2.41                     0.0084
  NOP2_HUMAN    Putative ribosomal RNA methyltransferase NOP2                    3                4.06        0.436                 2.29                     0.0138
  PGRC1_HUMAN   Membrane-associated progesterone receptor component 1            4                18.97       0.440                 2.27                     0.0210
  FINC_HUMAN    Fibronectin                                                      35               20.03       0.453                 2.21                     0.0002
  DHB12_HUMAN   Estradiol 17-beta-dehydrogenase 12                               3                11.54       0.454                 2.20                     0.0098
  DHB4_HUMAN    Peroxisomal multifunctional enzyme type 2                        11               25.00       0.479                 2.09                     0.0418
  TAGL_HUMAN    Transgelin                                                       15               75.12       0.482                 2.08                     0.0000
  OAT_HUMAN     Ornithine aminotransferase, mitochondrial                        5                14.12       0.487                 2.05                     0.0007
  LPPRC_HUMAN   Leucine-rich PPR motif-containing protein, mitochondrial         12               9.83        0.497                 2.01                     0.0403

  Accession     Protein name                                           Peptides (95%)   %Cov (95)   iTRAQ ratio ECs:TCs   Fold enrichment in ECs   *P*
  ------------- ------------------------------------------------------ ---------------- ----------- --------------------- ------------------------ --------
  H15_HUMAN     Histone H1.5                                           7                23.45       2.002                 2.00                     0.0037
  RL7A_HUMAN    60S ribosomal protein L7a                              6                21.80       2.009                 2.01                     0.0001
  PLOD1_HUMAN   Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1      13               20.22       2.063                 2.06                     0.0000
  FETUA_HUMAN   Alpha-2-HS-glycoprotein                                4                6.81        2.083                 2.08                     0.0373
  ALDOA_HUMAN   Fructose-bisphosphate aldolase A                       24               53.02       2.090                 2.09                     0.0000
  PEA15_HUMAN   Astrocytic phosphoprotein PEA-15                       2                16.92       2.100                 2.10                     0.0063
  PROF1_HUMAN   Profilin-1                                             23               75.71       2.107                 2.11                     0.0005
  TPIS_HUMAN    Triosephosphate isomerase                              20               64.26       2.137                 2.14                     0.0000
  CNN2_HUMAN    Calponin-2                                             9                37.86       2.156                 2.16                     0.0009
  ENOA_HUMAN    Alpha-enolase                                          46               73.27       2.172                 2.17                     0.0000
  DEST_HUMAN    Destrin                                                5                28.48       2.175                 2.18                     0.0118
  SH3L3_HUMAN   SH3 domain-binding glutamic acid-rich-like protein 3   3                34.41       2.185                 2.19                     0.0196
  H12_HUMAN     Histone H1.2                                           7                30.99       2.197                 2.20                     0.0056
  TGM2_HUMAN    Protein-glutamine gamma-glutamyltransferase 2          18               21.25       2.205                 2.21                     0.0247
  WDR1_HUMAN    WD repeat-containing protein 1                         10               18.15       2.218                 2.22                     0.0000
  GPX1_HUMAN    Glutathione peroxidase 1                               6                23.15       2.259                 2.26                     0.0005
  ACTN4_HUMAN   Alpha-actinin-4                                        44               42.15       2.269                 2.27                     0.0057
  P3H3_HUMAN    Prolyl 3-hydroxylase 3                                 4                7.74        2.275                 2.27                     0.0138
  COTL1_HUMAN   Coactosin-like protein                                 4                18.31       2.275                 2.27                     0.0125
  ITA5_HUMAN    Integrin alpha-5                                       7                8.20        2.320                 2.32                     0.0001
  RL24_HUMAN    60S ribosomal protein L24                              6                31.21       2.329                 2.33                     0.0009
  PDLI7_HUMAN   PDZ and LIM domain protein 7                           4                8.97        2.329                 2.33                     0.0027
  6PGD_HUMAN    6-phosphogluconate dehydrogenase, decarboxylating      5                10.77       2.360                 2.36                     0.0152
  PLST_HUMAN    Plastin-3                                              11               19.37       2.388                 2.39                     0.0000
  ZYX_HUMAN     Zyxin                                                  10               18.53       2.515                 2.51                     0.0234
  CSRP1_HUMAN   Cysteine and glycine-rich protein 1                    3                21.76       2.525                 2.53                     0.0014
  PDLI1_HUMAN   PDZ and LIM domain protein 1                           6                26.75       2.529                 2.53                     0.0001
  ACTN1_HUMAN   Alpha-actinin-1                                        37               38.68       2.557                 2.56                     0.0000
  DPYL2_HUMAN   Dihydropyrimidinase-related protein 2                  10               21.33       2.560                 2.56                     0.0032
  NTF2_HUMAN    Nuclear transport factor 2                             2                17.32       2.599                 2.60                     0.0162
  MOES_HUMAN    Moesin                                                 26               44.71       2.609                 2.61                     0.0004
  SPHM_HUMAN    N-sulphoglucosamine sulphohydrolase                    2                4.98        2.639                 2.64                     0.0049
  EHD2_HUMAN    EH domain-containing protein 2                         8                17.13       2.738                 2.74                     0.0007
  AMPN_HUMAN    Aminopeptidase N                                       7                7.03        2.760                 2.76                     0.0290
  VIME_HUMAN    Vimentin                                               200              83.69       2.833                 2.83                     0.0001
  CATB_HUMAN    Cathepsin B                                            7                23.89       2.985                 2.98                     0.0041
  PTRF_HUMAN    Polymerase I and transcript release factor             17               42.82       3.019                 3.02                     0.0019
  FLNB_HUMAN    Filamin-B                                              96               41.78       3.050                 3.05                     0.0000
  K6PP_HUMAN    6-phosphofructokinase type C                           5                8.29        3.090                 3.09                     0.0001
  TSP1_HUMAN    Thrombospondin-1                                       3                3.16        3.138                 3.14                     0.0056
  VAT1_HUMAN    Synaptic vesicle membrane protein VAT-1 homologue      12               31.81       3.235                 3.23                     0.0000
  HSPB1_HUMAN   Heat shock protein beta-1                              17               61.46       3.306                 3.31                     0.0311
  FSCN1_HUMAN   Fascin                                                 6                16.63       3.473                 3.47                     0.0000
  TPP1_HUMAN    Tripeptidyl-peptidase 1                                7                12.08       3.573                 3.57                     0.0200
  SDPR_HUMAN    Serum deprivation-response protein                     3                9.18        3.951                 3.95                     0.0004
  NEST_HUMAN    Nestin                                                 22               16.84       4.134                 4.13                     0.0004
  SYWC_HUMAN    Tryptophanyl-tRNA synthetase, cytoplasmic              3                8.70        4.389                 4.39                     0.0009
  TXND5_HUMAN   Thioredoxin domain-containing protein 5                15               40.51       5.918                 5.92                     0.0000
  EGLN_HUMAN    Endoglin                                               3                6.69        6.297                 6.30                     0.0067
  FABP5_HUMAN   Fatty acid-binding protein, epidermal                  4                16.30       7.134                 7.13                     0.0109
  MUC18_HUMAN   Cell surface glycoprotein MUC18                        7                12.69       9.313                 9.31                     0.0003
  FKB1A_HUMAN   Peptidyl-prolyl cis-trans isomerase FKBP1A             4                34.26       10.535                10.53                    0.0244
  PECA1_HUMAN   Platelet endothelial cell adhesion molecule            9                11.52       13.313                13.31                    0.0029
  VWF_HUMAN     von Willebrand factor                                  19               7.93        15.888                15.89                    0.0000
  CRIP2_HUMAN   Cysteine-rich protein 2                                2                14.90       100.000               100.00                   0.0137
  MARE1_HUMAN   Microtubule-associated protein RP/EB family member 1   2                7.46        100.000               100.00                   0.0186

TCs *versus* ECs 5th day in cell culture
----------------------------------------

### Up-regulated proteins

We identified, by comparison between TCs and ECs, that there are 38 proteins up-regulated in TCs, especially Myosin-14 (18.84-fold), superoxide dismutase (SOD2; 14.59-fold), acid ceramidase (AC; 7.63-fold), envoplakin and epiplakin (∽6-fold each).

### Down-regulated proteins

In TCs, compared to ECs there are 60 proteins down-regulated, especially cell surface glycoprotein MUC18 (15.54-fold), Ras-interacting protein 1 (13.42-fold), BTB/POZ domain-containing protein (7.26-fold), peptidyl prolyl cis/trans isomerase (6.65-fold) and nestin (5.92-fold) and von Willebrand factor (5.74-fold).

### Functional analysis of the identified proteins

The protein expression profiles were analysed with the aid of PANTHER Classification System and depicted in Figures[1](#fig01){ref-type="fig"}--[3](#fig03){ref-type="fig"} (details are given in Tables [S1](#sd5){ref-type="supplementary-material"} and [S2](#sd5){ref-type="supplementary-material"}). The highly expressed proteins in TCs are involved in important *molecular functions* such as: catalytic activity (17 proteins), structural molecule activity (13 proteins) as seen in Figure[1A](#fig01){ref-type="fig"} compared to ECs where significantly more proteins are involved in catalytic activity (30 proteins) and 29 proteins have molecular binding function (Fig.[1B](#fig01){ref-type="fig"}). In addition, in ECs, two up-regulated proteins are involved in nucleic acid-binding transcription and one has anti-oxidant activity.

![Molecular function classification of proteins found at day 5 in TCs (A) and in ECs (B). Bar graphs based on the PANTHER (Protein ANalysis THrough Evolutionary Relationships) system.](jcmm0018-1035-f1){#fig01}

![Analysis of differentially expressed proteins at day 5 in TCs *versus* ECs by biological process (A and B), cellular processes (C and D), developmental processes (E and F) and localization (G and H).](jcmm0018-1035-f2){#fig02}

![Bar graph representation of the distribution of identified proteins in TCs and ECs (cell culture, 5th day) according to their protein class (A and B), pathways (C and D) and cellular components (E and F) classification.](jcmm0018-1035-f3){#fig03}

Analysis of PANTHER *biological processes,* in which the 38 up-regulated proteins in TCs are involved, revealed that 18 proteins are responsible for metabolic processes and 15 proteins in *cellular processes* - Figure[2A](#fig02){ref-type="fig"}, such as cell communication (4 proteins), cytokinesis (2 proteins), cellular component movement (2 proteins), cell cycle (2 proteins) - Figure[2C](#fig02){ref-type="fig"}. Ten up-regulated proteins in TCs are involved in *developmental processes*: anatomical structure morphogenesis (10 proteins), mesoderm development (3 proteins), system development (2 proteins) and ectoderm development (1 protein) - Figure[2E](#fig02){ref-type="fig"}. Moreover, 10 proteins in TCs are related to *localization* processes such as vesicle mediated transport (4 proteins), protein transport (4 proteins) and ion transport (3 proteins) - Figure[2G](#fig02){ref-type="fig"}.

*Biological processes* of the ECs are related to 42 up-regulated proteins correlated with metabolic processes, 27 to *cellular processes* (Fig.[2B](#fig02){ref-type="fig"}) such as cell communication (11 proteins), cell cycle (7 proteins), cellular component movement (3 proteins), cytokinesis (2 proteins), chromosome segregation (1 protein) - Figure[2D](#fig02){ref-type="fig"}. There are 12 up-regulated proteins which are part of the *developmental processes* such as anatomical structure morphogenesis (8 proteins), system development (2 proteins), apoptotic processes (2 proteins), ectoderm development (1 protein) - Figure[2F](#fig02){ref-type="fig"}. Twelve proteins in ECs participate in *localization* processes *e.g*. protein transport (11 proteins), nuclear transport (8 proteins), vesicle mediated transport (2 proteins), RNA localization (2 proteins) and ion transport (1 protein) - Figure[2H](#fig02){ref-type="fig"}.

Interestingly to note, there are 6 up-regulated proteins in TCs compared to ECs involved in biological regulation and 5 related to response to stimulus.

The *protein classes* of the TCs enclose cytoskeletal proteins (12 proteins), oxidoreductase (8 proteins), structural proteins (7 proteins), transferase (5 proteins) *etc*. - Figure[3A](#fig03){ref-type="fig"}. The up-regulated TCs proteins belong to the following *pathways*: nicotinic acetylcholine receptor (2 proteins), inflammation mediated by chemokines (2 proteins), *de novo* purine biosynthesis (2 proteins), cytoskeletal regulation by Rho GTPase (2 proteins), TCA cycle (1 protein), Parkinson disease (1 protein), integrin signalling (1 protein) and blood coagulation (1 protein) - Figure[3C](#fig03){ref-type="fig"}. In TCs, the up-regulated proteins are related to the following *cellular components*: cell part (13 proteins), organelle (12 proteins), membrane (2 proteins), cell junction (2 proteins), extracellular region (1 protein) and extracellular matrix (1 protein) - Figure[3E](#fig03){ref-type="fig"}.

The up-regulated proteins in ECs are attributed to the following *protein classes*: enzyme modulator (11 proteins), cytoskeletal proteins (10 proteins), oxidoreductase (7 proteins), nucleic acid binding (6 proteins), transferase, isomerase and chaperone (5 proteins each), *etc*. - Figure[3B](#fig03){ref-type="fig"}. The *pathways* map depicted the ECs proteins are related to: integrin signalling pathway (3 proteins), Huntington disease (3 proteins), cytoskeletal regulation by Rho GTPase (3 proteins), pentose phosphate pathway (2 proteins), Parkinson disease (2 proteins), inflammation mediated by chemokines (2 proteins), glycolysis (2 proteins), *etc*. - Figure[3D](#fig03){ref-type="fig"}. The *cellular component* of ECs proteome demonstrated proteins related to: cell part (12 proteins), organelle (10 proteins), extracellular region (1 protein) and extracellular matrix (1 protein) - Figure[3F](#fig03){ref-type="fig"}.

The heat map showing the differentially expressed proteins between TCs and ECs, in cell culture after 5 days, can be observed in Figure[4](#fig04){ref-type="fig"}.

![Heat map generated from iTRAQ data by using PEAKS. It shows differential expression results between TCs and ECs (cell culture, 5th day). Experimental samples are clustered on the horizontal axis and protein spots on the vertical axis. Colours correspond to the level of the measurement: red indicates increased and green decreased expression ratio, while black squares indicate no change in protein abundance.](jcmm0018-1035-f4){#fig04}

TCs *versus* ECs, 10th day in cell culture
------------------------------------------

### Up-regulated proteins

Telocytes as compared to ECs, showed that there are 26 proteins up-regulated in TCs, especially prostacyclin synthase (8.93-fold), epiplakin (4.78-fold) and superoxide dismutase (4.50-fold).

### Down-regulated proteins

In TCs, compared to ECs there are 56 proteins down-regulated, especially microtubule-associated protein RP/EB family member 1 (100-fold), cysteine-rich protein 2 (100-fold), von Willebrand factor (15.89-fold) and platelet endothelial cell adhesion molecule (13.31-fold) peptidyl prolyl cis/trans isomerase (10.53-fold) and cell surface glycoprotein MUC18 (9.31-fold) - Table[2](#tbl2){ref-type="table"} (For details see Tables [S3](#sd5){ref-type="supplementary-material"} and [S4](#sd5){ref-type="supplementary-material"}).

### Functional analysis of the identified proteins

Figures[5](#fig05){ref-type="fig"}--[7](#fig07){ref-type="fig"} show the distributions of differentially proteins in putative functional categories. The highly expressed proteins in TCs are involved in important *molecular functions* such as: catalytic activity (15 proteins), structural molecule activity (10 proteins), binding (5 proteins), receptor activity (3 proteins), transporter activity (2 proteins) as seen in Figure[5A](#fig05){ref-type="fig"} compared to ECs where significantly more proteins are involved in binding (24 proteins), structural molecule activity (21 proteins), catalytic activity (20 proteins), nucleic acid-binding transcription (6 proteins), enzyme regulator activity (3 proteins), anti-oxidant activity (1 protein) - Figure[5B](#fig05){ref-type="fig"}.

![Molecular function classification of proteins found at day 10 in TCs (A) and in ECs (B). Bar graphs based on the PANTHER (Protein ANalysis THrough Evolutionary Relationships) system.](jcmm0018-1035-f5){#fig05}

![Analysis of differentially expressed proteinsat day 10 in TCs *versus* ECs by biological process (A and B), cellular processes (C and D), developmental processes (E and F) and localization (G and H).](jcmm0018-1035-f6){#fig06}

![Bar graph representation of the distribution of identified proteins in TCs and ECs (cell culture, 10th day) according to their protein class (A and B), pathways (C and D) and cellular components (E and F) classification.](jcmm0018-1035-f7){#fig07}

The 26 up-regulated proteins found in TCs were assigned to the following *biological processes* (according to PANTHER): metabolic processes (16 proteins), cellular processes (11 proteins), developmental processes (8 proteins), cellular component organization (8 proteins), *etc*. - (Fig.[6A](#fig06){ref-type="fig"}). The only *cellular process* which involve TCs up-regulated proteins is cell communication - Figure[6C](#fig06){ref-type="fig"}. Eight up-regulated proteins in TCs are involved in one *developmental process* - anatomical structure morphogenesis - Figure[6E](#fig06){ref-type="fig"}. Two proteins in TCs are related to *localization* processes such as vesicle mediated transport (1 protein) and protein transport (2 proteins) - Figure[6G](#fig06){ref-type="fig"}.

The 56 proteins found to be up-regulated in the ECs are assigned to the following *biological processes:* metabolic processes (32 proteins), cellular processes (27 proteins), developmental processes (18 proteins) - Figure[6B](#fig06){ref-type="fig"}. The *cellular processes* which involve ECs proteins are: cellular component movement (9 proteins), cell communication (5 proteins), cell cycle (2 proteins) - Figure[6D](#fig06){ref-type="fig"}. The main developmental processes which involve ECs proteins are: anatomical structure morphogenesis (13 proteins), system development (8 proteins), mesoderm development (5 proteins), ectoderm development (4 proteins), death (2 proteins), embryo development (1 protein) - Figure[6F](#fig06){ref-type="fig"}. Five proteins in ECs participate in localization processes *e.g*. protein transport (4 proteins), nuclear transport (3 proteins), vitamin transport (1 protein), vesicle mediated transport (1 protein), lipid transport (1 protein) - Figure[6H](#fig06){ref-type="fig"}.

The *protein classes* of the TCs enclose oxidoreductase (12 proteins), cytoskeletal proteins (8 proteins), structural proteins (6 proteins), transferase (5 proteins) *etc*. - Figure[7A](#fig07){ref-type="fig"}. The up-regulated TCs proteins belong to the following *pathways*: integrin signalling pathway (2 proteins) serine glycine biosynthesis (1 protein) - Figure[7C](#fig07){ref-type="fig"}. In TCs, the up-regulated proteins are related to the following *cellular components*: cell part (8 proteins), organelle (8 proteins), extracellular region (2 proteins) and extracellular matrix (1 protein) - Figure[7E](#fig07){ref-type="fig"}.

The up-regulated proteins in ECs are attributed to the following *protein classes*: cytoskeletal proteins (18 proteins), transcription factor (6 proteins), nucleic acid binding (6 proteins), hydrolase (5 proteins), oxidoreductase (4 proteins), structural protein (4 proteins), *etc*. - Figure[7B](#fig07){ref-type="fig"}. The *pathways* map depicted the ECs proteins are related to: integrin signalling pathway (4 proteins), glycolysis (2 proteins), *etc*. - Figure[7D](#fig07){ref-type="fig"}. The *cellular component* of ECs proteome demonstrated proteins related to: cell part (20 proteins), organelle (18 proteins), extracellular region (3 proteins) and extracellular matrix (3 proteins), membrane (1 protein), macromolecular complex (1 protein), cell junction (1 protein) - Figure[7F](#fig07){ref-type="fig"}.

The heat map presenting the differentially expressed proteins between TCs and ECs is showed in Figure[8](#fig08){ref-type="fig"} and demonstrate that the differences between this two cell types are still preserved in cell culture after 10 days.

![Differentially expressed proteins between TCs and ECs (cell culture, 10th day) were analysed by hierarchical clustering. In the heat map the experimental samples are clustered on the horizontal axis and protein spots on the vertical axis. Red: up-regulation; green: down-regulation; black: no change.](jcmm0018-1035-f8){#fig08}

Figures[9](#fig09){ref-type="fig"} and [10](#fig10){ref-type="fig"} use radar-chart representation of differentially expressed proteins between TCs and ECs at 5th day and at 10th day in cell cultures. Radar charts were chosen because they allow the visualization of a large numbers of proteins at the same time.

![Radar plots of proteomic profile for top proteins of TCs (A) and ECs (B) at 5th day in cell culture.](jcmm0018-1035-f9){#fig09}

![Radar plots of proteomic profile for top proteins of TCs (A) and ECs (B) at 10th day in cell culture.](jcmm0018-1035-f10){#fig10}

A String Network analysis was also performed to study the relation among differentially expressed proteins. In the global STRING-generated protein-protein network, several complexes and cellular functions formed prominent, tightly connected clusters as assessed by means of molecular complex detection (see Figs [S1](#sd1){ref-type="supplementary-material"}--[S4](#sd4){ref-type="supplementary-material"}). Figures[1](#fig01){ref-type="fig"} and [2](#fig02){ref-type="fig"} quantify protein-interaction properties of the TCs and ECs, respectively where the confidence view is presented and stronger associations are represented by thicker lines. These results indicate that while TCs are involved mainly in oxidation-reduction processes (Fig.[1A](#fig01){ref-type="fig"}), ECs are involved (as expected) in haemostasis (Fig.[2A](#fig02){ref-type="fig"}). Both cell types release extracellular vesicles (exosomes) \[[@b29],[@b49]\], however their content is different as indicated in Figures[1B](#fig01){ref-type="fig"} and [2B](#fig02){ref-type="fig"}.

![Protein interaction network generated with STRING. Major clusters of interacting proteins include those involved in oxidation-reduction process (A) and extracellular vesicular exosome (B) for TCs at day 5. Red nodes represent up-regulated proteins involved in these processes.](jcmm0018-1035-f11){#fig11}

![STRING analysis for ECs at day 5 investigating the interactions between up-regulated proteins and depicting ECs involvement in haemostasis (A) and extracellular vesicular exosome (B). Red nodes represent up-regulated proteins involved in these processes.](jcmm0018-1035-f12){#fig12}

Discussion
==========

Previously, we performed a proteomic analysis of human lung TCs compared to fibroblasts, at different time-points (the 5th and 10th day in primary cell culture) and we demonstrated that TCs protein expression profile is different \[[@b34]\]. The results were suggestive for specific roles of TCs in mechanical sensing and mechanic-chemical conversion task, tissue homoeostasis and remodelling/renewal. In addition, the presence of some proteins, specific for extracellular vesicles, emphasize TCs roles in intercellular signalling and stem cell niche modulation \[[@b19],[@b34],[@b50]\].

Beyond scientific interest in general, the comparison of TCs with ECs has a specific purpose. Both TCs and ECs are immunohistochemically CD34 positive, but while ECs are CD31 positive, TCs are CD31 negative. The present proteomic comparison confirms these immunohistochemical differences.

Putative roles of differentially expressed proteins
---------------------------------------------------

We previously showed that **myosin-14** which is the main up-regulated protein in TCs make these cells candidates for a *mechanical sensing and mechanochemical conversion task* \[[@b34]\].

Telocytes proteome revealed the presence of **SOD2 (SODM)**, a tetrameric anti-oxidative enzyme located in the mitochondrial matrix, encoded by genes located on chromosome 6 (6q25.3). The enzyme has manganese in its reactive centre, and catalyse the dismutation of superoxide (O~2~^−^) into oxygen and hydrogen peroxide. SOD2 act as a cytoprotective enzyme proved to be essential for the survival of aerobic organisms \[[@b51]\]. It also serves as *key anti-oxidant* being considered a *tumour suppressor protein via* modulating redox-related transcriptional factors \[[@b52]\].

**Acid ceramidase**, (an enzyme encoded by the ASAH1 gene) which was found to be up-regulated in TCs, is located in lysosomes and active at acidic pH \[[@b53]\]. It was shown to have a noteworthy position in cancer biology: high AC activity leads to an enhanced cell growth, while low AC activity leads to reduced cell growth through an enhanced ceramide response \[[@b54]\]. Also, AC has been shown to play important roles in tumour pathogenesis, and in resistance to therapy having a key role in controlling the ceramide-sphingosine-sphingosine-1-phosphate (S1P) balance that regulates cellular homoeostasis\[[@b55]\]. Therefore, we can hypothesize that TCs might have pro-proliferative effects through the inhibition of apoptosis through the regulation of inter-conversion of ceramide, sphingosine and S1P.

**Envoplakin** is a protein that in humans is encoded by the EVPL gene, and it is a member of a family of large multi-domain molecules \[[@b56]\]. Periplakin (195 kD) and envoplakin (210 kD) are closely related and have various functions to link cytoskeletal elements together and to connect them to junctional complexes. As we previously suggested, the presence of plakins in TCs is related to their homo and heterocellular junctions and it might be related to mechanical sensing and mechanochemical conversion task \[[@b34]\]. Plakins may also have additional roles in signal transduction \[[@b56]\].

Endothelial cells proteomic analysis revealed that proteins like microtubule-associated protein RP/EB family member 1, **MUC18**, **cysteine-rich protein 2**, **von Willebrand factor** (15.89-fold) and **platelet endothelial cell adhesion molecule** were found to be up-regulated at 5th day and also at 10th day in ECs culture. Microtubule-associated protein RP/EB family member 1 is a ubiquitously expressed protein which binds to the plus end of microtubules and regulates the dynamics of the microtubule cytoskeleton, probably playing a role in cell migration \[[@b57]\]. **MUC18 (CD146)** is a glycoprotein detected in endothelial cells as a surface receptor that triggers a transient increase in the intracellular calcium concentration \[[@b58]\]. **Cysteine-rich protein (CRP) 2** is a member of the LIM-only CRP family, also expressed in vascular smooth muscle cells (VSMCs) of blood vessels \[[@b59]\]. Its role is to repress VSMC migration and vascular remodelling, because it was demonstrated that the absence of CRP2 increases neointima formation, correlating with increased VSMC migration \[[@b60]\]. **von Willebrand factor** is a haemostatic protein stored in Weibel Palade bodies (considered as a hallmark of endothelial cells) until release \[[@b61]\]. In addition, we identified Ras-interacting protein 1 (RAIN) as being overexpressed in ECs. We can consider RAIN - known to be essential for endothelial cell morphogenesis and blood vessel tubulogenes - as being a part of the specific signature for ECs, in consistency with other recent proteomic study \[[@b62]\].

We found no significant differences between protein expression, in ECs, at 5 days and at 10 days.

Our present results suggest that TCs are cells relatively rich in mitochondria, which correlates with previous findings \[[@b34]\]. The primary functions of mitochondria include: generating energy by oxidative phosphorylation, creating reactive oxygen species (ROS) and regulating apoptosis. It is also known that cellular ageing is influenced by oxidative phosphorylation, ROS and telomeres. Therefore, this study enabled us to suggest TCs involvement in the modulation of oxidative stress levels which might lead to a rigorous control in apoptosis activation. This finding is also in agreement with the fact that TCs are decreasing during ageing of myocardium (work in progress).

This study provides a comprehensive approach to analyse the comparative proteome between TCs and ECs and we can conclude that the significant discriminative power of each of the proteins mentioned above supports the case for TCs as distinctive cells, while ECs are characterized by the already known marker molecules such as MUC18 and von Willebrand factor. Also, it supports once more the idea of TCs involvement in tissue homoeostasis and in stem cell activity, as previously suggested by our group.

Moreover, it stands for a recent perspective suggested by Smithies and Edelstein considering TCs as a very primitive nervous system at the cellular level which can play a major role in morphogenetic bioelectrical signalling \[[@b63],[@b64]\].

In conclusion, the current proteomic analysis presented here, clearly depicts that TCs are completely different from ECs. Protein expression profile demonstrates that TCs might play specific roles in intercellular signaling and also as physical and/or chemical sensors. Their close relationships with stem cells should not be overlooked.
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**Figure S1** STRING analysis of up-regulated proteins in TCs at day 5 representing the confidence view where stronger associations are represented by thicker lines.

**Figure S2** STRING analysis of up-regulated proteins in ECs at day 5 representing the confidence view where stronger associations are represented by thicker lines.

**Figure S3** STRING analysis of up-regulated proteins in TCs at day 10 representing the confidence view where stronger associations are represented by thicker lines.

**Figure S4** STRING analysis of up-regulated proteins in ECs at day 10 representing the confidence view where stronger associations are represented by thicker lines.

**Table S1** Summary of up-regulated TCs proteins (more than twofold) versus ECs 5th day.

**Table S2** Summary of up-regulated ECs proteins (more than twofold) versus TCs 5th day.

**Table S3** Summary of up-regulated TCs proteins (more than twofold) versus ECs 10th day.

**Table S4** Summary of up-regulated ECs proteins (more than twofold) versus TCs 10th day.
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